Keyword: Pascal Soriot

News

AstraZeneca's New CEO Removes R&D, Commercial Heads

15.01.2013 - AstraZeneca's new chief executive stamped his authority on the struggling drugmaker on Tuesday by removing the heads of research and commercial operations. Pascal Soriot, who took...

News

New AstraZeneca CEO Gets $6.4 Million for Jumping Ship

29.10.2012 - Struggling British drugmaker AstraZeneca is giving its new chief executive Pascal Soriot 4 million pounds ($6.44 million) compensation for loss of long-term incentives from his...

News

New CEO Has Work Cut Out as AstraZeneca Sales Fall

25.10.2012 - AstraZeneca's sales slumped 19% in the third quarter, underscoring the scale of the challenge confronting the drugmaker's new chief executive, Pascal Soriot. Faced with patent...

News

AstraZeneca Suspends Share Buyback Program

01.10.2012 - AstraZeneca has suspended its share buyback program, giving new chief executive Pascal Soriot more leeway to devise a strategy to return the British drugmaker to growth. The...

News

AstraZeneca Grabs Roche Pharma Head as New CEO

28.08.2012 - AstraZeneca has poached Pascal Soriot from rival Roche Holding to be its new chief executive, hoping his track record in drug innovation and dealmaking can revive a company...